| Literature DB >> 34064607 |
Zalán Benedek1, Szabolcs Todor-Boér2, Loránd Kocsis3, Orsolya Bauer1, Nicolae Suciu1, Marius Florin Coroș1.
Abstract
Background andEntities:
Keywords: Clavien-Dindo classification; colorectal cancer; psoas muscle index; sarcopenia
Mesh:
Year: 2021 PMID: 34064607 PMCID: PMC8151336 DOI: 10.3390/medicina57050472
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430
Figure 1A quick tracing of the right (R) psoas muscle at the third lumbar vertebra (L3) level using DICOM Viewer software which automatically generates the area.
Clavien Dindo postoperative complication scale (Dindo et al. 2004).
|
|
|
|---|---|
|
| Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Acceptable therapeutic regimens are: drugs as antiemetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside |
|
| Requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusions and total parenteral nutrition are also included. |
|
| Requiring surgical, endoscopic or radiological intervention |
|
| intervention not under general anesthesia |
|
| intervention under general anesthesia |
|
| Life-threatening complication (including Central nervous system (CNS) complications)* requiring IC/ICU-management |
|
| single organ dysfunction (including dialysis) |
|
| multi organ dysfunction |
|
| Death of a patient |
|
| If the patient suffers from a complication at the time of discharge, the suffix “d” (for ‘disability’) is added to the respective grade of complication. This label indicates the need for a follow-up to fully evaluate the complication |
* Brain hemorrhage, ischemic stroke, subarrachnoidal bleeding, but excluding transient ischemic attacks (TIA); IC: Intermediate care; ICU: Intensive care unit.
The frequency of cancer localization.
| Characteristics | N (Number of Cases) | % |
|---|---|---|
| Cancer localization | ||
| Rectal | 29 | 56.9 |
| Right colon | 13 | 25.5 |
| Sigmoid | 6 | 11.8 |
| Left colon | 3 | 5.9 |
Frequency of complications by Clavien-Dindo grade.
| Postoperative Complications | N | % |
|---|---|---|
| Clavien-Dindo Complication Grade | ||
| No complication (0) | 30 | 58.8 |
| Grade I | 12 | 23.5 |
| Grade II | 4 | 7.8 |
| Grade III | 2 | 3.9 |
| Grade IV | 1 | 2.0 |
| Grade V | 2 | 3.9 |
Patient characteristics by Clavien-Dindo complication grade.
| Characteristic | All ( | Clavien-Dindo Complication Grade | |||
|---|---|---|---|---|---|
| 0 a ( | 1–2 b ( | 3–5 c ( |
| ||
|
| |||||
| Age (years) | 65 (56–71) | 62 (55–71) | 64 (59–69) | 70 (69–71) | 0.512 |
| Sex, male/female, n (%) | 31 (61)/20 (39) | 24 (80)/6(20) | 5(31)/11(69) | 2(40)/3(60) | 0.003 |
| BMI (kg/m2) | 26.3 (23.9–30.1) | 27.6 (24.9–30.4) | 23.7 (22.9–28.2) | 25.6 (25.5–26.9) | 0.074 |
|
| |||||
| Symptom duration (days) | 3 (2–6) | 3 (2–5) | 3.5 (1–6) | 3 (2–3) | 0.517 |
| Hemorrhage, n (%) | 23 (45) | 12 (40) | 8 (50) | 3 (60) | 0.637 |
| Loss in weight (kg) | 5 (0–10) | 3 (0–35) | 6 (0–20) | 8 (0–30) | 0.941 |
| Meteorism, n (%) | 18 (25) | 10 (33) | 5 (31) | 3 (60) | 0.490 |
| Diarrhea, n (%) | 21 (41) | 15 (50) | 3 (19) | 3 (60) | 0.069 |
| Constipation, n (%) | 16 (31) | 8 (27) | 4 (25) | 4 (80) | 0.059 |
| Abdominal pain, n (%) | 23 (45) | 13 (43) | 7 (44) | 3 (60) | 0.780 |
| Fatiguability, n (%) | 18 (35) | 8 (27) | 8 (50) | 2 (40) | 0.284 |
|
| |||||
| White blood cells (/μL) | 7560 (6000–8560) | 7000 (5500–8230) | 7845 (6925–8525) | 8030 (6200–8720) | 0.454 |
| Hematocrit (%) | 39 (32–42) | 42 (39–45) | 33 (30–38) | 32 (29–40) | 0.002 |
| Hemoglobin (g/dL) | 12.6 (9.9–14.0) | 13.5 (12.4–14.4) | 9.9 (9.5–11.5) | 10.8 (9.1–12.5) | 0.001 |
| Platelet (x103/μL) | 246 (208–299) | 237 (193–267) | 255 (228–299) | 255 (208–423) | 0.192 |
| ALT (U/L) | 14 (10–25) | 14 (10–25) | 15.5 (9–29.5) | 13 (12–17) | 0.915 |
| AST (U/L) | 17 (13–29) | 15 (13–24) | 17.5 (12–32.5) | 18 (17–31) | 0.563 |
| Total protein (g/L) | 69 (62–73) | 69 (67–73) | 67 (58–72) | 55 (54–76) | 0.318 |
| Albumin (g/L) | 40 (37–43) | 41 (39–43) | 37 (35–39) | 33 (32–42) | 0.008 |
| Na+ (mEq/L) | 140 (138–142) | 141 (139–143) | 140 (138–142) | 136 (136–138) | 0.019 |
| K+ (mEq/L) | 4.3 (4.0–4.6) | 4.4 (4–4.7) | 4.2 (4.1–4.5) | 4.3 (3.9–4.4) | 0.618 |
| Creatinine (mg/dL) | 0.77 (0.72–0.89) | 0.78 (0.74–0.86) | 0.73 (0.66–0.84) | 1.07 (0.74–1.31) | 0.105 |
| ESR (mm/h) | 37 (16–62) | 30 (8–50) | 46 (28–76) | 24 (14–50) | 0.121 |
| CRP (mg/L) | 0.7 (0.3–1.7) | 0.4 (0.2–0.9) | 1.0 (0.6–2.0) | 2.7 (1.3–2.9) | 0.043 |
|
| |||||
| Right psoas area (cm2) | 10.2 (8.5–11.9) | 11.3 (10.2–12.7) | 7.9 (6.7–8.9) | 8.3 (7.8–11.1) | <0.001 |
| Left psoas area (cm2) | 10.3 (8.3–12.6) | 12.3 (11.4–13.2) | 8.3 (6.5–9.4) | 8.5 (7.9–10.1) | <0.001 |
| Total psoas area (cm2) | 20.9 (16.7–24.3) | 23.3 (21.1–25.8) | 15.9 (13.6–18.3) | 16.9 (15.6–21.2) | <0.001 |
| Psoas muscle index (cm2/m2) | 7.2 (5.9–8.2) | 8.1 (7.3–8.6) | 5.8 (5.1–6.1) | 6.8 (5.9–7.3) | <0.001 |
| Mean density (HU) | 36.0 (30.5–40.3) | 36.5 (32.0–40.5) | 34.0 (39.8–41.0) | 32.0 (28.0–37.5) | 0.343 |
a = No complication, b = Low grade (complication requiring minor intervention), c = High grade (complication requiring significant intervention). BMI = body mass index, ALT = alanine transaminase, AST = aspartate transaminase, ESR = erythrocyte sedimentation rate, CRP = C-reactive protein, HU = Hounsfield unit. Data are presented as median (interquartile range) or as frequencies and percentages.
Logistic regression analysis of risk factors for occurrence of complication vs. no complications.
| Low-Grade | ||
|---|---|---|
| Predictors | OR(Odds Ratio) | |
|
| ||
| Female gender | 8.80 (2.20–35.14) | 0.001 |
|
| ||
| Hematocrit | 0.87 (0.79–0.97) | 0.013 |
| Hemoglobin | 0.55 (0.38–0.79) | 0.002 |
| CRP | 1.35 (0.88–2.06) | 0.159 |
| Albumin | 0.75 (0.61–0.92) | 0.006 |
| Na+ | 0.91 (0.72–1.15) | 0.459 |
|
| ||
| Right psoas area | 0.11 (0.02–0.50) | 0.005 |
| Left psoas area | 0.18 (0.05–0.61) | 0.006 |
| Total psoas area | 0.33 (0.16–0.72) | 0.005 |
| Psoas muscle index | 0.05 (0.01–0.31) | 0.002 |
|
| ||
|
|
|
|
|
| ||
| Female gender | 6.00 (0.81–44.35) | 0.076 |
|
| ||
| Hematocrit | 0.90 (0.81–1.01) | 0.080 |
| Hemoglobin | 0.64 (0.42–0.98) | 0.041 |
| CRP | 1.56 (0.88–2.78) | 0.125 |
| Albumin | 0.78 (0.61–0.98) | 0.038 |
| Na+ | 0.64 (0.44–0.93) | 0.022 |
|
| ||
| Right psoas area | 0.41 (0.19–0.88) | 0.022 |
| Left psoas area | 0.45 (0.24–0.85) | 0.014 |
| Total psoas area | 0.64 (0.44–0.91) | 0.016 |
| Psoas muscle index | 0.26 (0.08–0.85) | 0.027 |